Health Benefits and Biological Activity of Ginger Phytochemicals Against Chronic Diseases and Cancers

Ahmad Mandeel Alzahrani; Hani Yousef Abdullah; Hani Abdulfatah Alturkistani; Hani Yahya Alfaifi; Fayez Mushayil Alshehri; Abdulgader Hussain Albar

doi:10.55544/jrasb.1.3.35

Authors

Ahmad Mandeel Alzahrani Department of Microbiology and Parasitology, Faculty of Medicine, King Abdulaziz University, Jeddah, SAUDI ARABIA.
Hani Yousef Abdullah Department of Microbiology and Parasitology, Faculty of Medicine, King Abdulaziz University, Jeddah, SAUDI ARABIA.
Hani Abdulfatah Alturkistani Department of Microbiology and Parasitology, Faculty of Medicine, King Abdulaziz University, Jeddah, SAUDI ARABIA.
Hani Yahya Alfaifi Department of Anatomy, Faculty of Medicine, King Abdulaziz University, Jeddah, SAUDI ARABIA.
Fayez Mushayil Alshehri Department of Biology, College of Science, University of Jeddah, Jeddah, SAUDI ARABIA.
Abdulgader Hussain Albar Department of Microbiology and Parasitology, College of Medicine, University of Jeddah, Jeddah, SAUDI ARABIA.

DOI:

https://doi.org/10.55544/jrasb.1.3.35

Keywords:

Anticancer, Bioactive components, Ginger phytochemicals

Abstract

As cancer prevalence escalates significantly across the globe, fighting this terminal illness using phytochemicals is considered a green anticancer therapeutic approach. Many plants contain useful bioactive compounds that can influence cancer remedies positively. Moreover, these bioactive compounds derived from natural sources exhibited great vital contribution activities such as antioxidant, anti-inflammatory, and antimicrobial. Since antiquity, ginger was used in folk medicine as a reason for its ability to relieve systemic pain and food flavoring. Along with recent findings and discoveries, ginger and its derived phenolic compounds such as 6-gingerol, 8-gingerol, and 10-gingerol, shogaol, parasols, zingerone, and α-curcumene, each independently or collectively is well known to contribute prospectively in an accessible way in many chronic conditions such as obesity, diabetes, non-alcoholic fatty liver disease, Alzheimer disease, rheumatoid arthritis, asthma, and chronic kidney disease. On the other hand, drug-based ginger's pharmacological properties show significant suppression of specific cancers such as skin, colorectal, pancreatic, prostate, breast, lung, AML, gastric, and HCC through series of distinctive mechanisms. It is notably now that these ginger characteristics, along with its beneficial flavonoid contents, are a novel therapeutic approach in a variety of ailments.

Downloads

Download data is not yet available.

Metrics

Metrics Loading ...

References

G. H. Observatory, “WHO Cancer,” World Health Organization, 2018. https://www.who.int/news-room/fact-sheets/detail/cancer

S. Wu, W. Zhu, P. Thompson, and Y. A. Hannun, “Evaluating intrinsic and non-intrinsic cancer risk factors,” Nature Communications, vol. 9, no. 1, 2018, doi: 10.1038/s41467-018-05467-z.

G. International Agency for Research on Cancer, “CANCER TODAY,” POPULATION FACT SHEETS. https://gco.iarc.fr/today (accessed Aug. 11, 2022).

J. Ferlay et al., “Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012,” International Journal of Cancer, vol. 136, no. 5, pp. E359–E386, 2015, doi: 10.1002/ijc.29210.

L. Countries, J. A. De Souza, B. Hunt, F. C. Asirwa, C. Adebamowo, and G. Lopes, “Global Health Equity : Cancer Care Outcome Disparities in,” vol. 34, no. 1, pp. 4–6, 2016, doi: 10.1200/JCO.2015.62.2860.

P. E. Huber et al., “Trimodal cancer treatment: Beneficial effects of combined antiangiogenesis, radiation, and chemotherapy,” Cancer Research, vol. 65, no. 9, pp. 3643–3655, 2005, doi: 10.1158/0008-5472.CAN-04-1668.

J. Iqbal, B. A. Abbasi, T. Mahmood, S. Kanwal, B. Ali, and S. A. Shah, “Plant-derived anticancer agents: A green anticancer approach,” Asian Pacific Journal of Tropical Biomedicine, vol. 7, no. 12, pp. 1129–1150, 2017, doi: 10.1016/j.apjtb.2017.10.016.

A. Ghasemzadeh, H. Z. E. Jaafar, and A. Rahmat, “Optimization protocol for the extraction of 6-gingerol and 6-shogaol from Zingiber officinale var . rubrum Theilade and improving antioxidant and anticancer activity using response surface methodology,” pp. 1–10, 2015, doi: 10.1186/s12906-015-0718-0.

F. Fadaki, M. Modaresi, and I. Sajjadian, “The Effects of Ginger Extract and Diazepam on Anxiety Reduction in Animal Model,” vol. 51, no. 3, pp. 159–162, 2017, doi: 10.5530/ijper.51.3s.4.

S. College, D. Jalna, and M. S. Pin, “Study of Nutritious Values of Ginger,” no. 38, pp. 732–734, 2020.

A. D. Nazhvani, N. Sarafraz, F. Askari, F. Heidari, and M. Razmkhah, “Anti-Cancer Effects of Traditional Medicinal Herbs on Oral Squamous Cell Carcinoma,” vol. 21, pp. 479–484, 2020, doi: 10.31557/APJCP.2020.21.2.479.

S. Priya and P. K. Satheeshkumar, “Natural products from plants: Recent developments in phytochemicals, phytopharmaceuticals, and plant-based neutraceuticals as anticancer agents,” Functional and Preservative Properties of Phytochemicals, pp. 145–163, Jan. 2020, doi: 10.1016/B978-0-12-818593-3.00005-1.

J. Iqbal et al., “Biomedicine & Pharmacotherapy Potential phytochemicals in the fi ght against skin cancer : Current landscape and future perspectives,” vol. 109, no. June 2018, pp. 1381–1393, 2019, doi: 10.1016/j.biopha.2018.10.107.

M. A. Ashraf, “Phytochemicals as Potential Anticancer Drugs: Time to Ponder Nature’s Bounty,” BioMed Research International, vol. 2020. 2020. doi: 10.1155/2020/8602879.

P. Borah, “Medicinal plants and their compounds with anticancer properties,” Green Approaches in Medicinal Chemistry for Sustainable Drug Design, pp. 759–776, Jan. 2020, doi: 10.1016/B978-0-12-817592-7.00023-X.

A. Ali et al., “Protective effects of ginger extract against the toxicity of cyclophosphamide on testes: an experimental laboratory-based study,” International Journal of Medicine in Developing Countries, no. March, pp. 280–285, 2020, doi: 10.24911/ijmdc.51-1558600986.

N. H. Anh et al., “Ginger on human health: A comprehensive systematic review of 109 randomized controlled trials,” Nutrients, vol. 12, no. 1, pp. 1–28, 2020, doi: 10.3390/nu12010157.

I. U. Rahman et al., “Herbal teas and drinks: Folk medicine of the manoor valley, lesser himalaya, pakistan,” Plants, vol. 8, no. 12, pp. 1–18, 2019, doi: 10.3390/plants8120581.

G. Vernin and C. Parkanyi, “Chemistry of ginger,” in Ginger: The Genus Zingiber, CRC Press, 2016, pp. 87–180. doi: 10.1201/9781420023367-7.

L. J. Jing, M. Mohamed, A. Rahmat, and M. F. A. Bakar, “Phytochemicals, antioxidant properties and anticancer investigations of the different parts of several gingers species (Boesenbergia rotunda, Boesenbergia pulchella var attenuata and Boesenbergia armeniaca),” Journal of Medicinal Plants Research, vol. 4, no. 1, pp. 027–032, 2010, doi: 10.5897/JMPR09.308.

V. S. Govindarajan, “Ginger — chemistry, technology, and quality evaluation: Part 1,” C R C Critical Reviews in Food Science and Nutrition, vol. 17, no. 1, pp. 1–96, 1983, doi: 10.1080/10408398209527343.

S. K. Jo et al., “An impression on current developments in the technology, chemistry, and biological activities of ginger (Zingiber officinale Roscoe).,” European food research & technology., vol. 242, no. 1, pp. 651–688, 2016, doi: 10.1080/10408398209527343.

R. Karunakaran and S. P. Sadanandan, “Zingiber officinale: Antiinflammatory Actions and Potential Usage for Arthritic Conditions,” in Bioactive Food as Dietary Interventions for Arthritis and Related Inflammatory Diseases, Elsevier, 2019, pp. 233–244. doi: 10.1016/B978-0-12-813820-5.00013-1.

Canadian Cancer Society, “Antinausea drugs,” 2020. https://www.cancer.ca/en/cancer-information/diagnosis-and-treatment/managing-side-effects/nausea-and-vomiting/antinausea-drugs/?region=sk

R. Yamprasert, W. Chanvimalueng, N. Mukkasombut, and A. Itharat, “Ginger extract versus Loratadine in the treatment of allergic rhinitis: a randomized controlled trial,” BMC Complementary Medicine and Therapies, vol. 20, no. 1, 2020, doi: 10.1186/s12906-020-2875-z.

J. Seidi, S. Ebnerasooli, S. Shahsawari, and S. Nzarian, “The Influence of Oral Ginger before Operation on Nausea and Vomiting after Cataract Surgery under General Anesthesia: A double-blind placebo-controlled randomized clinical trial,” Electron Physician, vol. 9, no. 1, pp. 3508–3514, 2017, doi: 10.19082/3508.

P. Mandal, A. Das, S. Majumdar, T. Bhattacharyya, T. Mitra, and R. Kundu, “The efficacy of ginger added to ondansetron for preventing postoperative nausea and vomiting in ambulatory surgery,” Pharmacognosy Research, vol. 6, no. 1, pp. 52–57, 2014, doi: 10.4103/0974-8490.122918.

E. Soltani, A. Jangjoo, M. Afzal Aghaei, and A. Dalili, “Effects of preoperative administration of ginger (Zingiber officinale Roscoe) on postoperative nausea and vomiting after laparoscopic cholecystectomy,” Journal of Traditional and Complementary Medicine, vol. 8, no. 3, pp. 387–390, 2018, doi: 10.1016/j.jtcme.2017.06.008.

C.-Z. Wang, J. Moss, and C.-S. Yuan, “Commonly Used Dietary Supplements on Coagulation Function during Surgery,” Medicines, vol. 2, no. 3, pp. 157–185, 2015, doi: 10.3390/medicines2030157.

H. Pakniat et al., “The effect of ginger and metoclopramide in the prevention of nausea and vomiting during and after surgery in cesarean section under spinal anesthesia,” Obstetrics and Gynecology Science, vol. 63, no. 2, pp. 173–180, 2020, doi: 10.5468/ogs.2020.63.2.173.

H. Vahdatpoor, S. Shakerian, A. A. Alizadeh, and S. R. FatemiTabatabaei, “The Ginger Supplementation Effects on Aerobic Power Training Capacity and Dysmenorrhea in Overweight Girls,” Iranian journal of diabetes and obesity, vol. 11, no. 2, pp. 93–98, 2020, doi: 10.18502/ijdo.v11i2.2654.

J. L. Funk, J. B. Frye, J. N. Oyarzo, J. Chen, H. Zhang, and B. N. Timmermann, “Anti-inflammatory effects of the essential oils of ginger (Zingiber officinale Roscoe) in experimental rheumatoid arthritis,” PharmaNutrition, vol. 4, no. 3, pp. 123–131, 2016, doi: 10.1016/j.phanu.2016.02.004.

S. Sayed, M. Ahmed, A. El-shehawi, and M. Alkafafy, “Ginger Water Reduces Body Weight Gain and Improves Energy Expenditure in Rats,” vol. 9, no. 38, pp. 1–14, 2020.

“Diagnosis and classification of diabetes mellitus,” Diabetes Care, vol. 37, no. SUPPL.1, p. S81 LP-S90, Jan. 2014, doi: 10.2337/dc14-S081.

WHO Global Report, “Global Report on Diabetes,” 2016.

C. K. Wei et al., “6-Paradol and 6-Shogaol, the Pungent Compounds of Ginger, Promote Glucose Utilization in Adipocytes and Myotubes, and 6-Paradol Reduces Blood Glucose in High-Fat Diet-Fed Mice,” International Journal of Molecular Sciences, vol. 18, no. 1, pp. 1–18, 2017, doi: 10.3390/ijms18010168.

J. D. N. Ascencio Camargo, A. S. Bertan, I. V. de Almeida, V. E. P. Vicentini, E. Dusman, and L. T. D. Tonin, “Antitumoral activity, antioxidant capacity and bioactive compounds of ginger (Zingiber officinale),” Acta Scientiarum - Technology, vol. 42, no. 1, pp. 1–11, 2020, doi: 10.4025/actascitechnol.v42i1.45724.

A. Ebrahimzadeh, A. Ebrahimzadeh, S. M. Mirghazanfari, E. Hazrati, S. Hadi, and A. Milajerdi, “The effect of ginger supplementation on metabolic profiles in patients with type 2 diabetes mellitus: A systematic review and meta-analysis of randomized controlled trials,” Complementary Therapies in Medicine, vol. 65. Churchill Livingstone, May 01, 2022. doi: 10.1016/j.ctim.2022.102802.

I. B. McInnes and G. Schett, “Pathogenetic insights from the treatment of rheumatoid arthritis,” The Lancet, vol. 389, no. 10086, pp. 2328–2337, 2017, doi: 10.1016/S0140-6736(17)31472-1.

Gibofsky A, “Overview of epidemiology, pathophysiology, and diagnosis of rheumatoid arthritis.,” The American Journal of Managed Care, pp. 18(13 Suppl):S295-302, 2012.

M. C. Boissier, L. Semerano, S. Challal, N. Saidenberg-Kermanac’h, and G. Falgarone, “Rheumatoid arthritis: From autoimmunity to synovitis and joint destruction,” Journal of Autoimmunity, vol. 39, no. 3, pp. 222–228, 2012, doi: 10.1016/j.jaut.2012.05.021.

E. Choy, “Understanding the dynamics: Pathways involved in the pathogenesis of rheumatoid arthritis,” Rheumatology (United Kingdom), vol. 51, no. SUPPL.5, pp. 3–11, 2012, doi: 10.1093/rheumatology/kes113.

S. Neidhart and M. Neidhart, “Rheumatoid arthritis and the concept of autoimmune disease,” Int. J. Clin. Rheumatol, vol. 14, no. 2, pp. 75–79, 2019.

S. Safiri et al., “Global, regional and national burden of rheumatoid arthritis 1990–2017: a systematic analysis of the Global Burden of Disease study 2017,” Annals of the Rheumatic Diseases, vol. 78, no. 11, pp. 1463 LP – 1471, Nov. 2019, doi: 10.1136/annrheumdis-2019-215920.

J. L. Funk, J. B. Frye, J. N. Oyarzo, and B. N. Timmermann, “Comparative effects of two gingerol-containing zingiber officinale extracts on experimental Rheumatoid arthritis,” Journal of Natural Products, vol. 72, no. 3, pp. 403–407, 2009, doi: 10.1021/np8006183.

J. L. Funk, J. B. Frye, J. N. Oyarzo, J. Chen, H. Zhang, and B. N. Timmermann, “Anti-inflammatory effects of the essential oils of ginger (Zingiber officinale Roscoe) in experimental rheumatoid arthritis,” PharmaNutrition, vol. 4, no. 3, pp. 123–131, 2016, doi: 10.1016/j.phanu.2016.02.004.

N. Aryaeian, F. Shahram, M. Mahmoudi, H. Tavakoli, B. Yousefi, and T. Arablou, “The effect of ginger supplementation on some immunity and inflammation intermediate genes expression in patients with active Rheumatoid Arthritis,” Gene, vol. 698, pp. 179–185, 2019, doi: 10.1016/j.gene.2019.01.048.

C. Amit, A. Rajeshwar, K. Kant, P. G. Raj, and T. Bhawna, “Formulation and Evaluation of Ginger Extract Loaded Nanoemulgel for the Treatment of Rheumatoid Arthritis,” vol. 9, no. 4, pp. 559–570, 2019.

T. Deng, C. J. Lyon, S. Bergin, M. A. Caligiuri, and W. A. Hsueh, Obesity, Inflammation, and Cancer, vol. 11, no. 1. 2016. doi: 10.1146/annurev-pathol-012615-044359.

J. Upadhyay, O. Farr, N. Perakakis, W. Ghaly, and C. Mantzoros, “Obesity as a Disease,” Medical Clinics of North America, vol. 102, no. 1, pp. 13–33, 2018, doi: 10.1016/j.mcna.2017.08.004.

World Health Orginization WHO, “Obesity and overweight,” WHO, 2020. https://www.who.int/news-room/fact-sheets/detail/obesity-and-overweight

Y. C. Chooi, C. Ding, and F. Magkos, “The epidemiology of obesity,” Metabolism: Clinical and Experimental, vol. 92, pp. 6–10, 2019, doi: 10.1016/j.metabol.2018.09.005.

J. E. Hall, J. M. do Carmo, A. A. da Silva, Z. Wang, and M. E. Hall, “Obesity, kidney dysfunction and hypertension: mechanistic links,” Nature Reviews Nephrology, vol. 15, no. 6, pp. 367–385, 2019, doi: 10.1038/s41581-019-0145-4.

A. Romero-Corral et al., “Accuracy of body mass index in diagnosing obesity in the adult general population,” International Journal of Obesity, vol. 32, no. 6, pp. 959–966, 2008, doi: 10.1038/ijo.2008.11.

K. B. Smith and M. S. Smith, “Obesity Statistics,” Primary Care: Clinics in Office Practice, vol. 43, no. 1, pp. 121–135, Mar. 2016, doi: 10.1016/j.pop.2015.10.001.

A. G. Mainous, R. J. Tanner, K. P. Rahmanian, A. Jo, and P. J. Carek, “Effect of Sedentary Lifestyle on Cardiovascular Disease Risk Among Healthy Adults With Body Mass Indexes 18.5 to 29.9 kg/m 2,” American Journal of Cardiology, vol. 123, no. 5, pp. 764–768, 2019, doi: 10.1016/j.amjcard.2018.11.043.

F. Q. Nuttall, “Body mass index: Obesity, BMI, and health: A critical review,” Nutrition Today, vol. 50, no. 3, pp. 117–128, 2015, doi: 10.1097/NT.0000000000000092.

O. A. Varban, A. J. Bonham, J. F. Finks, D. A. Telem, N. R. Obeid, and A. A. Ghaferi, “Is it worth it? Determining the health benefits of sleeve gastrectomy in patients with a body mass index <35 kg/m2,” Surgery for Obesity and Related Diseases, vol. 16, no. 2, pp. 248–253, 2020, doi: 10.1016/j.soard.2019.10.027.

M. Blüher, “Obesity: global epidemiology and pathogenesis,” Nature Reviews Endocrinology, vol. 15, no. 5, pp. 288–298, 2019, doi: 10.1038/s41574-019-0176-8.

C. Hales, M. Carroll, C. Fryar, and C. Ogden, “Prevalence of Obesity and Severe Obesity Among Adults: United States, 2017-2018,” NCHS Data Brief, vol. 360, no. 360, pp. 1–8, 2020.

E. Porrini, M. Navarro-Díaz, R. Rodríguez-Rodríguez, and E. Salido, “Renal Disease in Obesity, Metabolic Syndrome and Diabesity,” Diabetic Nephropathy, pp. 65–80, 2019, doi: 10.1007/978-3-319-93521-8_5.

N. M. Iyengar, C. A. Hudis, and A. J. Dannenberg, “Obesity and Cancer: Local and Systemic Mechanisms,” Annual Review of Medicine, vol. 66, no. 1, pp. 297–309, 2015, doi: 10.1146/annurev-med-050913-022228.

J. Wang, P. Wang, D. Li, X. Hu, and F. Chen, “Beneficial effects of ginger on prevention of obesity through modulation of gut microbiota in mice,” European Journal of Nutrition, vol. 59, no. 2, pp. 699–718, 2020, doi: 10.1007/s00394-019-01938-1.

H.-C. Chang, K.-W. Kan, J.-H. Chen, Y.-H. Lin, Y.-H. Lin, and C.-M. Kuan, “The Synergistic Effect of Lotus Leaf , Chinese Hawthorn ,” vol. 8, no. 3, pp. 133–138, 2020, doi: 10.12691/jfnr-8-3-3.

G. N. Dalekos, N. K. Gatselis, K. Zachou, and G. K. Koukoulis, “NAFLD and autoimmune hepatitis: Do not judge a book by its cover,” European Journal of Internal Medicine, 2020, doi: 10.1016/j.ejim.2020.02.001.

S. Stender, N. Grarup, and T. Hansen, “Genetic aspects of non-alcoholic fatty liver disease (NAFLD),” The Human Gut-Liver-Axis in Health and Disease, pp. 195–206, 2018, doi: 10.1007/978-3-319-98890-0_12.

S. Li et al., “The Impacts of Herbal Medicines and Natural Products on Regulating the Hepatic Lipid Metabolism,” Frontiers in Pharmacology, vol. 11, no. March, 2020, doi: 10.3389/fphar.2020.00351.

R. Rafie, S. A. Hosseini, E. Hajiani, A. S. Malehi, and S. A. Mard, “Effect of ginger powder supplementation in patients with non-alcoholic fatty liver disease: A randomized clinical trial,” Clinical and Experimental Gastroenterology, vol. 13, pp. 35–45, 2020, doi: 10.2147/CEG.S234698.

M. Rahimlou, Z. Yari, A. Hekmatdoost, S. M. Alavian, and S. A. Keshavarz, “Ginger supplementation in nonalcoholic fatty liver disease: A randomized, double-blind, placebo-controlled pilot study,” Hepatitis Monthly, vol. 16, no. 1, pp. 1–5, 2016, doi: 10.5812/hepatmon.34897.

T. M. Okda, M. M. Abd-Alhaseeb, K. Barka, and N. M. Ragab, “Ginger potentiates the effects of silymarin on liver fibrosis induced by CCL4: The role of galectin-8,” European Review for Medical and Pharmacological Sciences, vol. 23, no. 2, pp. 885–891, 2019, doi: 10.26355/eurrev_201901_16903.

K. A. Mahdy et al., “Protective Effect of Ginger (Zingiber officinale) on Alzheimer’s disease Induced in Rats,” 2014.

M. Mathew and S. Subramanian, “In vitro evaluation of anti-Alzheimer effects of dry ginger (Zingiber officinale Roscoe) extract,” Indian Journal of Experimental Biology, vol. 52, no. 6, pp. 606–612, 2014.

J. G. Choi, S. Y. Kim, M. Jeong, and M. S. Oh, “Pharmacotherapeutic potential of ginger and its compounds in age-related neurological disorders,” Pharmacology and Therapeutics, vol. 182, pp. 56–69, 2018, doi: 10.1016/j.pharmthera.2017.08.010.

A. M. El Halawany, N. S. El Sayed, H. M. Abdallah, and R. S. El Dine, “Protective effects of gingerol on streptozotocin-induced sporadic Alzheimer’s disease: Emphasis on inhibition of β-amyloid, COX-2, alpha-, beta - secretases and APH1a,” Scientific Reports, vol. 7, no. 1, pp. 1–11, 2017, doi: 10.1038/s41598-017-02961-0.

M. Gauthier, A. Ray, and S. E. Wenzel, “Evolving concepts of asthma,” American Journal of Respiratory and Critical Care Medicine, vol. 192, no. 6, pp. 660–668, 2015, doi: 10.1164/rccm.201504-0763PP.

H. Wang, N. Li, and H. Huang, “Asthma in Pregnancy: Pathophysiology, Diagnosis, Whole-Course Management, and Medication Safety,” Canadian Respiratory Journal, vol. 2020, 2020, doi: 10.1155/2020/9046842.

S. B. de Nijs, L. N. Venekamp, and E. H. Bel, “Adult-onset asthma: Is it really different?,” European Respiratory Review, vol. 22, no. 127, pp. 44–52, 2013, doi: 10.1183/09059180.00007112.

A. Bontinck, T. Maes, and G. Joos, “Asthma and air pollution: recent insights in pathogenesis and clinical implications,” Curr Opin Pulm Med, vol. 26, no. 1, pp. 10–19, 2020, doi: 10.1097/MCP.0000000000000644.

Y. Zhang, Q. Xiang, C. Yu, and Z. Yang, “Asthma mortality is triggered by short-term exposures to ambient air pollutants: Evidence from a Chinese urban population,” Atmospheric Environment, vol. 223, 2020, doi: 10.1016/j.atmosenv.2020.117271.

G. T. Yocum, J. J. Hwang, M. Mikami, J. Danielsson, A. S. Kuforiji, and C. W. Emala, “Ginger and its bioactive component 6-shogaol mitigate lung inflammation in a murine asthma model,” Am J Physiol Lung Cell Mol Physiol, vol. 318, no. 2, pp. L296–L303, 2020, doi: 10.1152/ajplung.00249.2019.

M. Kardan, A. Rafiei, J. Ghaffari, R. Valadan, Z. Morsaljahan, and S. T. Haj-ghorbani, “Effect of ginger extract on expression of GATA3, T-bet and ROR-γt in peripheral blood mononuclear cells of patients with Allergic Asthma,” Allergologia et Immunopathologia, vol. 47, no. 4, pp. 378–385, 2019, doi: 10.1016/j.aller.2018.12.003.

A. M. Khan, M. Shahzad, M. B. Raza Asim, M. Imran, and A. Shabbir, “Zingiber officinale ameliorates allergic asthma via suppression of Th2-mediated immune response,” Pharmaceutical Biology, vol. 53, no. 3, pp. 359–367, 2015, doi: 10.3109/13880209.2014.920396.

K. Kalantar-Zadeh, T. H. Jafar, D. Nitsch, B. L. Neuen, and V. Perkovic, “Chronic kidney disease,” The Lancet, vol. 398, no. 10302, pp. 786–802, Aug. 2021, doi: 10.1016/S0140-6736(21)00519-5.

C. P. Kovesdy, “Epidemiology of chronic kidney disease: an update 2022,” Kidney International Supplements, vol. 12, no. 1, pp. 7–11, Apr. 2022, doi: 10.1016/j.kisu.2021.11.003.

N. H. Lameire et al., “Harmonizing acute and chronic kidney disease definition and classification: report of a Kidney Disease: Improving Global Outcomes (KDIGO) Consensus Conference,” Kidney International, vol. 100, no. 3, pp. 516–526, Sep. 2021, doi: 10.1016/j.kint.2021.06.028.

F. Irshad, S. Munawar, and A. Rasheed, “Effects Of Ginger Extract On Glomerular Mesangial Matrix Of Kidneys In Alloxan Induced Diabetic Nephropathy Of Albino Rats,” Journal of Bahria University Medical and Dental College, vol. 08, no. 02, pp. 87–91, Jun. 2018, doi: 10.51985/JBUMDC2018036.

H. Imani, H. Tabibi, I. Najafi, S. Atabak, M. Hedayati, and L. Rahmani, “Effects of ginger on serum glucose, advanced glycation end products, and inflammation in peritoneal dialysis patients,” Nutrition, vol. 31, no. 5, pp. 703–707, May 2015, doi: 10.1016/j.nut.2014.11.020.

M.-G. Gwon, H. Gu, J. Leem, and K.-K. Park, “Protective Effects of 6-Shogaol, an Active Compound of Ginger, in a Murine Model of Cisplatin-Induced Acute Kidney Injury,” Molecules, vol. 26, no. 19, p. 5931, Sep. 2021, doi: 10.3390/molecules26195931.

Q. Q. Mao et al., “Bioactive compounds and bioactivities of ginger (zingiber officinale roscoe),” Foods, vol. 8, no. 6, pp. 1–21, 2019, doi: 10.3390/foods8060185.

R. Karunakaran and S. P. Sadanandan, “Zingiber officinale: Antiinflammatory Actions and Potential Usage for Arthritic Conditions,” Bioactive Food as Dietary Interventions for Arthritis and Related Inflammatory Diseases, pp. 233–244, 2019, doi: 10.1016/b978-0-12-813820-5.00013-1.

M. H. Mughal, “6-Gingerol and Shogaol ; A Comprehensive Strategy Against Various Maladies,” Significances of Bioengineering & Biosciences, vol. 3, no. 1, pp. 1–5, 2019, doi: 10.31031/SBB.2019.03.000.

M. da S. Vasconcelos, E. F. Mota, N. F. Gomes-Rochette, D. C. S. Nunes-Pinheiro, S. M. Nabavi, and D. F. de Melo, “Ginger (Zingiber officinale Roscoe),” in Nonvitamin and Nonmineral Nutritional Supplements, Elsevier, 2018, pp. 235–239. doi: 10.1016/B978-0-12-812491-8.00034-5.

R. M. T. de Lima et al., “Protective and therapeutic potential of ginger (Zingiber officinale) extract and [6]-gingerol in cancer: A comprehensive review,” Phytotherapy Research, vol. 32, no. 10, pp. 1885–1907, 2018, doi: 10.1002/ptr.6134.

D. W. Connell, “Chemistry of the essential oil and oleoresin of ginger (Zingiber officinale).,” The Flavour Industry, no. 10, pp. 677–693, 1970.

R. Bhandari and J. P. Sethiya, “A Pharmacological Investigation of Zingiber Officinale,” vol. 5, no. October, pp. 465–469, 2018.

M. H. Yang, J. Kim, I. A. Khan, L. A. Walker, and S. I. Khan, “Nonsteroidal anti-inflammatory drug activated gene-1 (NAG-1) modulators from natural products as anti-cancer agents,” Life Sciences, vol. 100, no. 2. Pergamon, pp. 75–84, Apr. 01, 2014. doi: 10.1016/j.lfs.2014.01.075.

S. M. Hu, X. H. Yao, Y. H. Hao, A. H. Pan, and X. W. Zhou, “8-Gingerol regulates colorectal cancer cell proliferation and migration through the EGFR/STAT/ERK pathway,” International Journal of Oncology, vol. 56, no. 1, pp. 390–397, 2020, doi: 10.3892/ijo.2019.4934.

D. P. Mansingh, S. Pradhan, D. Biswas, R. Barathidasan, and H. R. Vasanthi, “Palliative Role of Aqueous Ginger Extract on N-Nitroso-N-Methylurea-Induced Gastric Cancer,” Nutrition and Cancer, vol. 72, no. 1, pp. 157–169, 2019, doi: 10.1080/01635581.2019.1619784.

J. S. Sidhu and T. A. Zafar, “Indian herbal medicine and their functional components in cancer therapy and prevention,” Functional Foods in Cancer Prevention and Therapy, pp. 169–194, 2020, doi: 10.1016/b978-0-12-816151-7.00010-7.

N. S. Al-Abbas, “Can Ginger (<i>Zingiber officinale</i>) Aqueous Crude Extract Induce Apoptotic Pathways in Drug-Resistance Acute Myeloid Leukemia: <i>In Vitro</i> Study?,” Advances in Biological Chemistry, vol. 09, no. 03, pp. 99–109, 2019, doi: 10.4236/abc.2019.93008.

S. Y. Chen et al., “Enhancing the anticancer activity of Antrodia cinnamomea in hepatocellular carcinoma cells via cocultivation with ginger: The impact on cancer cell survival pathways,” Frontiers in Pharmacology, vol. 9, no. JUL, pp. 1–13, 2018, doi: 10.3389/fphar.2018.00780.

Z. Wu et al., “Anticancer effects of β-elemene with hyperthermia in lung cancer cells,” Experimental and Therapeutic Medicine, vol. 13, no. 6, pp. 3153–3157, 2017, doi: 10.3892/etm.2017.4350.

D. Nedungadi et al., “Ginger extract activates caspase independent paraptosis in cancer cells via ER stress, mitochondrial dysfunction, AIF translocation and DNA damage,” Nutrition and Cancer, 2019, doi: 10.1080/01635581.2019.1685113.

S. Rahimi Babasheikhali, S. Rahgozar, and M. Mohammadi, “Ginger extract has anti-leukemia and anti-drug resistant effects on malignant cells,” Journal of Cancer Research and Clinical Oncology, vol. 145, no. 8, pp. 1987–1998, 2019, doi: 10.1007/s00432-019-02949-5.

C. xu Wang, L. xia Wang, C. yu Li, C. Hu, and S. hua Zhao, “Anti-proliferation activities of three bioactive components purified by high-speed counter-current chromatography in essential oil from ginger,” European Food Research and Technology, vol. 246, no. 4, pp. 795–805, 2020, doi: 10.1007/s00217-020-03446-7.

A. Mohammed et al., “In-vitro Anticancer and Cytotoxic Activity of Ginger Extract on Human Breast Cell Lines,” no. 1, pp. 26–29, 2020.

K. G. Soroush Sarami, Maryam Dadmanesh, Zuhair M. Hassan, “Study on the Effect of Ethanol Ginger Extract on Cell Viability And p53 Level in Breast and Pancreatic Cancer,” Archives of Pharmacy Practice, vol. 11, no. 3, pp. 115–121, 2020.

M. S. Baliga et al., “Update on the chemopreventive effects of ginger and its phytochemicals,” Critical Reviews in Food Science and Nutrition, vol. 51, no. 6, pp. 499–523, 2011, doi: 10.1080/10408391003698669.

M. Brahmbhatt, S. R. Gundala, G. Asif, S. A. Shamsi, and R. Aneja, “Ginger phytochemicals exhibit synergy to inhibit prostate cancer cell proliferation,” Nutrition and Cancer, vol. 65, no. 2, pp. 263–272, 2013, doi: 10.1080/01635581.2013.749925.

M. Singh, P. Singh, and Y. Shukla, “New strategies in cancer chemoprevention by phytochemicals,” Frontiers in Bioscience - Elite 2020, vol. 4 E, no. 1, pp. 426–452, 2012, doi: 10.2741/e389.

J. Rhode et al., “Ginger inhibits cell growth and modulates angiogenic factors in ovarian cancer cells,” BMC Complementary and Alternative Medicine, vol. 7, 2007, doi: 10.1186/1472-6882-7-44.

S. R. Gundala et al., “Enterohepatic recirculation of bioactive ginger phytochemicals is associated with enhanced tumor growth-inhibitory activity of ginger extract,” Carcinogenesis, vol. 35, no. 6, pp. 1320–1329, 2014, doi: 10.1093/carcin/bgu011.

M. J. Tuorkey, “Cancer Therapy with Phytochemicals: Present and Future Perspectives,” Biomedical and Environmental Sciences, vol. 28, no. 11, pp. 808–819, 2015, doi: 10.1016/S0895-3988(15)30111-2.